United States
US 12,702,717 B2
Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody
US 12,702,717 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Sowakai Medical Foundation; National University Corporation Tokai National Higher Education and Research System. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Sowakai Medical Foundation; National University Corporation Tokai National Higher Education and Research System
- Inventors
- Atsushi ENOMOTO; Nobutoshi ESAKI; Masahide TAKAHASHI; Yuki MIYAI; Ryota ANDO; Yukihiro SHIRAKI; Yoshihiro NISHIDA; Makoto MATSUYAMA; Shino MANABE
- Publication date
- 2026-08-11
- Filing date
- 2022-08-02
- Document type
- B2 Granted patent
- Also written as
- US 12,702,717 B2 · US12702717 · 12702717
Abstract
An anti-MEFLIN antibody and a pharmaceutical composition comprising the antibody is described. The pharmaceutical composition may comprise an antibody-drug conjugate (ADC) of the anti-MEFLIN antibody and a cytotoxic agent, which may be connected to each other by a linker. The pharmaceutical composition may be used in the treatment of a cancer in a subject.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free